Citations 1
636 A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc T cell engager in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
Uboha, Nataliya V. , Chaves, Jorge, Chen, Christopher T. , Powderly, John D. , Zhaohui, Jin, Alistar, Angela , Gabrail, Nashat , Agensky, Laura, Goel, Apollina, Margossian, Steven, Levisetti, Matteo, Quayle, Steve, Kim, Dae Won , Alese, Olatunji B. , Saenger, Yvonne M. , Zheng, Lei , Fu, Siqing , Gong, Jun , Zhaohui, Jin, Bekaii‐Saab, Tanios , Selfridge, Jennifer Eva
Regular and Young Investigator Award Abstracts | November 5, 2024 | Volume: No volume available | Issue: No issue available | Pages: A730-A730
